Weaver Lab
Bone and Cartilage Development and Disease

PUBLICATIONS

This is an accordion element with a series of buttons that open and close related content panels.

Selected Publications

  1. Weaver SR*, Doolittle ML, Durdan MM, Narum AK, Weivoda MM, Alhamad DW, McGee-Lawrence ME, Khosla S, Taylor EL, Bradley EW, Fernandez de Velasco EM, Wickman K, Westendorf JJ. 2025. Global but not myeloid-lineage Girk3 deletion increases bone mass in female mice. Journal of Bone and Mineral Research Plus: ziaf133.
  2. Weaver SR, Peralta-Herrera E, Torres HM, Jessen E, Bradley EW, Westendorf JJ. 2024. Phlpp1 alters the murine chondrocyte phospho-proteome during endochondral bone formation. Bone 189: 117265.
  3. Weaver SR, Arnold KM, Peralta-Herrera E, Oviedo M, Zars EL, Bradley EW, Westendorf JJ. 2024. Postnatal deletion of Phlpp1 in chondrocytes delays post-traumatic osteoarthritis in male mice. Osteoarthritis and Cartilage Open 7(1):100525. doi: 10.1016/j.ocarto.2024.100525.
  4. Weaver SR, Torres HM, Arnold KM, Zars EL, Peralta-Herrera E, Taylor EL, Yu K, Marron Fernandez de Velasco E, Wickman K, McGee-Lawrence ME, Bradley EW, Westendorf JJ. 2024. Girk3 deletion increases osteoblast maturation and bone mass accrual in adult male mice. Journal of Bone and Mineral Research Plus 8(10): ziae108.
  5. Arnold KM, Weaver SR, Zars EL, Tschumperlin DJ, Westendorf JJ. 2023. Inhibition of Phlpp1 preserves the mechanical integrity of cartilage in a murine model of post-traumatic osteoarthritis. Osteoarthritis and Cartilage 32(6): 680-689.
  6. Torres HM, Arnold KM, Oviedo M, Westendorf JJ, Weaver SR. 2023. Inflammatory processes affecting bone health and repair. Current Osteoporosis Reports 21(6): 842-853.
  7. Taylor EL*, Weaver SR*, Lorang IM, Arnold KM, Bradley EW, Fernandez de Velasco EM, Wickman K, Westendorf JJ. 2022. Girk3 deletion facilitates kappa opioid signaling in chondrocytes, delays vascularization, and promotes bone lengthening in mice. Bone 159: 116391. *authors contributed equally
  8. Weaver SR*, Taylor EL*, Zars EL, Arnold KM, Bradley EW, Westendorf JJ. 2021. PH domain and leucine rich repeat phosphatase 1 (Phlpp1) suppresses parathyroid hormone receptor 1 (Pth1r) expression and signaling during bone growth. Journal Bone Miner Res 36(5): 986-999. *authors contributed equally
  9. Weaver SR, Fricke HP, Xie C, Charles JF, Hernandez LL. 2018. In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning. Sci Rep 9(1): 238.
  10. Weaver SR, Fricke HP, Xie C, Aiello RJ, Charles JF, Hernandez LL. 2018. Peripartum dietary supplementation of a dietary inhibitor of tryptophan hydroxylase 1 (TPH1) compromises infant, but not maternal, bone. Am J Physiol Endocrinol Metab 315(6): E1133-E1142.
  11. Weaver SR, Fricke HP, Maerz NL, Vezina CM, Charles JF, Hernandez LL. 2018. Peripartum fluoxetine reduces maternal trabecular bone post-weaning and elevates mammary gland serotonin and PTHrP. Endocrinology 159(8): 2850-2862.

My NCBI Bibliography

Link to my full NCBI Bibliography